A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects
Status:
Completed
Trial end date:
2019-06-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, pharmacokinetics and
pharmacodynamics of single ascending doses of ABP-671 administered orally in healthy
volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.